MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2024 International Congress

    Assessing Executive Function in HD: Comparing the One Touch Stockings of Cambridge and Zindametrix’s Tower-Z as Components of the HD-CAB

    M. Roche, G. Phelan, N. Sinha, A. Patel, A. Mansbach, H. Wilkinson, R. Fuller, J. Stout, S. Lazic, I. Antonijevic, S. Sathe, C. Sampaio (Princeton, USA)

    Objective: To assess the comparability of performance by people with Huntington’s disease (HD) on two tower tasks. Background: Cognitive decline is a hallmark feature of…
  • 2024 International Congress

    Validation Study of the Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest)

    V. Stopic, S. Jost, J. Haupt, G. Brandt, C. Vander Linden, JN. Petry-Schmelzer, T. Dembek, G. Fink, L. Batzu, A. Rizos, R. Chaudhuri, H. Dafsari, D. Gruber, G. Ebersbach, J. Kessler, M. Barbe, A. Sauerbier (Cologne, Germany)

    Objective: To test the psychometric properties of the newly developed Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest). Background: Stigma is a significant aspect of Parkinson’s disease (PD).…
  • 2024 International Congress

    Quantitative Analysis of the Biomechanical Contributors during the miniBEST Clinical Scale for Assessing Risk of Falling in Parkinson’s Disease

    T. Fitzgerald, C. O'Keeffe, J. Inocentes, E. Murphy, M. Bradley, C. Fearon, R. Reilly (Dublin, Ireland)

    Objective: The objective of this study was to determine the most relevant biomechanical factors contributing to the risk of falling in those with Parkinson’s Disease…
  • 2024 International Congress

    Movement Disorder Society Unified Parkinson’s Disease Rating Scale Motor Examination Retains Its 2-Domain Profile in Both On and Off States

    T. Mestre, G. Stebbins, C. Goetz, S. Luo (Ottawa, Canada)

    Objective: This study aims to validate the two-domain structure of MDS-UPDRS Part III items in both medication states, exploring the discriminative ability of the tremor…
  • 2024 International Congress

    Decline in functionality according to WHODAS 2.0 associated with disease progression in people with Parkinson’s disease

    N. Pereira, K. Nóbrega, I. Nascimento, L. Matos, L. Aranha, C. de Paula, C. Santana, R. Bocicovar, G. Campos, F. Fidelis, G. Dos Santos, I. Barone, V. Ponciano, M. Piemonte (São Paulo, Brazil)

    Objective: To investigate the decline in functionality according to WHODAS-2.0 from early to intermediate stages of PD. Background: Parkinson's disease (PD) is an incurable and…
  • 2024 International Congress

    Depression and Cognitive Phenotype in Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Results of a Comparative Study of a New Scale ESDEPARK Assessing Depressive Symptomatology Specifically in IPDWD vs a General Geriatric Depression Scale.

    C A. Hurtado-Gonzalez, S. Ospina-Otalvaro, J F. Ayala-Rico, J M. Márquez, F. Rojas, P A. Gutiérrez-Lenis, K. Rivera, S. Guerrero (Cali, Colombia)

    Objective: To show the Preliminary Results of the ESDEPARK and compare them with a General Geriatric Depression Scale in a sample of patients with IPDWD.…
  • 2024 International Congress

    Patient-reported changes from normal in individuals with prodromal and early-motor Parkinson’s disease: a scoping review

    J. Saade, T. Mestre, G. Stebbins, A. van Wyk (Ottawa, Canada)

    Objective: To synthesize published literature about patient-reported symptoms (PRS) or changes from normal in prodromal and early motor stages of Parkinson’s disease (PD) and develop…
  • 2024 International Congress

    Depressive Symptomatology and Neuropsychiatric Profile in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.

    C A. Hurtado-Gonzalez, J F. Ayala-Rico, S. Ospina-Otalvaro, J M. Márquez, L. Ortega-Bolaños, D A. Reyes-Torres, P A. Gutiérrez-Lenis, L M. Saldarriaga, C O. Moreno (Cali, Colombia)

    Objective: : To identify whether depression in patients with IPDWD correlates with different types of behavioral symptoms. Background: Depression is considered a frequent neuropsychiatric pathology…
  • 2023 International Congress

    Patient perspectives on symptoms and functional impacts to inform a digital assessment of Parkinson’s disease

    B. Fehlmann, A. Thomann, E. Davies, J. Twiss, C. Romano, D. Whalley, M. Mayorga, C. Levy, F. Lipsmeier, W. Popp, T. Kustermann, H. Svoboda, T. Nikolcheva, D. Trundell, M. Lindemann, K. Taylor (demuro)

    Objective: The aim of this study is to map patients’ reports of functional limitations and impacts of Parkinson’s disease (PD) to motor signs captured with…
  • 2023 International Congress

    Correlation of Functional Motor Assessments Used at Parkinson’s disease by Physiotherapists in Clinical Practice

    APC. Loureiro, B. Yamaguchi, VL. Israel (Curitiba, Brazil)

    Objective: The aim of this study was to verify whether there is a correlation between UPDRS motor score and non-specific assessments for PD commonly used…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley